Results 111 to 120 of about 14,587 (196)

Table_2_Cluster Differences in Antibiotic Resistance, Biofilm Formation, Mobility, and Virulence of Clinical Enterobacter cloacae Complex.docx

open access: yes, 2022
Due to the lack of research on the characteristics of different clusters of Enterobacter cloacae complex (ECC), this study aimed to characterize and explore the differences among species of the ECC.
Xiangkuo Zheng (7402763)   +9 more
core   +1 more source

Refractive Index Spectral Fingerprints of Pathogenic Bacteria Revealed by Monte Carlo‐Optimized Opto‐Microfluidic Extinction Spectroscopy

open access: yesJournal of Biophotonics, Volume 19, Issue 6, June 2026.
A physics‐informed opto‐microfluidic platform reconstructs refractive index spectra of pathogenic bacteria through Monte Carlo‐based inverse modeling. These optical fingerprints enable label‐free species identification with 97.75% accuracy using a one‐dimensional convolutional neural network, demonstrating a scalable biophotonic strategy for rapid ...
Quoc‐Thinh Dinh   +7 more
wiley   +1 more source

Table_1_Multidrug-Resistant Enterobacter cloacae Complex Emerging as a Global, Diversifying Threat.XLSX

open access: yes, 2019
The Enterobacter cloacae complex (ECC) includes common nosocomial pathogens capable of producing a wide variety of infections. Broad-spectrum antibiotic resistance, including the recent emergence of resistance to last-resort carbapenems, has led to ...
Anne-Catrin Uhlemann (299063)   +2 more
core   +1 more source

Molecular Characterization of KPC-2-Producing Enterobacter cloacae Complex Isolates from Cali, Colombia

open access: yes, 2021
The Enterobacter cloacae complex is an emerging opportunistic pathogen whose increased resistance to carbapenems is considered a public health problem. This is due to the loss of efficacy of beta-lactam antibiotics, which are used as the first treatment ...
Aura Falco   +6 more
core   +1 more source

Efficacy and Safety of Azacitidine Combined With Lisaftoclax in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome With Increased Blasts

open access: yeseJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Objective To retrospectively analyze the early efficacy and safety of azacitidine plus lisaftoclax in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome with increased blasts (MDS‐IB), providing a reliable clinical reference.
Shan Meng   +9 more
wiley   +1 more source

Table_2_Multidrug-Resistant Enterobacter cloacae Complex Emerging as a Global, Diversifying Threat.XLSX

open access: yes, 2019
The Enterobacter cloacae complex (ECC) includes common nosocomial pathogens capable of producing a wide variety of infections. Broad-spectrum antibiotic resistance, including the recent emergence of resistance to last-resort carbapenems, has led to ...
Anne-Catrin Uhlemann (299063)   +2 more
core   +1 more source

Liquid Chromatography‐Electrospray Ionization‐Tandem Mass Spectrometry Profiling, Antioxidant, Antibacterial, and Antidiabetic Properties of Fagonia cretica L.: Insights From In Vitro and In Silico Approaches

open access: yesChemistryOpen, Volume 15, Issue 6, June 2026.
Fagonia cretica L.: Phytochemical investigation and exploration of bioactivity through in vitro and in silico approaches. This study provides an integrative evaluation of the aqueous extract of Fagonia cretica L., a species long employed in traditional medicine but insufficiently characterized through systematic experimental and computational ...
Neghmouche Nacer Salah   +8 more
wiley   +1 more source

Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 46, Issue 6, June 2026.
ABSTRACT Background Intravenous push (IVP) administration of cefepime increases ease of preparation and limits the need for small volume parenterals. The data on IVP pharmacokinetic/pharmacodynamic (PK/PD) parameters are limited, but may be especially relevant in critically ill patients with altered PK/PD for time‐dependent antibiotics like cefepime ...
Susan E. Smith   +8 more
wiley   +1 more source

Image_1_Multidrug-Resistant Enterobacter cloacae Complex Emerging as a Global, Diversifying Threat.TIF

open access: yes, 2019
The Enterobacter cloacae complex (ECC) includes common nosocomial pathogens capable of producing a wide variety of infections. Broad-spectrum antibiotic resistance, including the recent emergence of resistance to last-resort carbapenems, has led to ...
Anne-Catrin Uhlemann (299063)   +2 more
core   +1 more source

Species‐Specific Optimisation and Environmental Regulation of Biofilm Formation in Enterobacter cloacae: Inhibitory Role of Glucose in Biofilm Development

open access: yesEnvironmental Microbiology Reports, Volume 18, Issue 3, June 2026.
This study demonstrates that mild salinity stress (1%–2% NaCl) significantly enhances biofilm formation in Enterobacter cloacae. Using a standardised 96‐well microtiter plate assay, we optimised in vitro biofilm quantification and classification, providing a reproducible framework for studying environmental and clinical biofilm development mechanisms ...
Srishti Singh   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy